Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109633

Appearance and Characterization of Lipoprotein X during Continuous Intralipid Infusions in the Neonate

E. Griffin, W. C. Breckenridge, A. Kuksis, M. H. Bryan, and A. Angel

Research Institute, The Hospital for Sick Children, Toronto, Canada

Lipid Research Clinic, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Banting and Best, Department of Medical Research, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Find articles by Griffin, E. in: PubMed | Google Scholar

Research Institute, The Hospital for Sick Children, Toronto, Canada

Lipid Research Clinic, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Banting and Best, Department of Medical Research, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Find articles by Breckenridge, W. in: PubMed | Google Scholar

Research Institute, The Hospital for Sick Children, Toronto, Canada

Lipid Research Clinic, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Banting and Best, Department of Medical Research, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Find articles by Kuksis, A. in: PubMed | Google Scholar

Research Institute, The Hospital for Sick Children, Toronto, Canada

Lipid Research Clinic, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Banting and Best, Department of Medical Research, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Find articles by Bryan, M. in: PubMed | Google Scholar

Research Institute, The Hospital for Sick Children, Toronto, Canada

Lipid Research Clinic, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Banting and Best, Department of Medical Research, University of Toronto, Toronto, Canada

Department of Medicine, University of Toronto, Toronto, Canada

Find articles by Angel, A. in: PubMed | Google Scholar

Published December 1, 1979 - More info

Published in Volume 64, Issue 6 on December 1, 1979
J Clin Invest. 1979;64(6):1703–1712. https://doi.org/10.1172/JCI109633.
© 1979 The American Society for Clinical Investigation
Published December 1, 1979 - Version history
View PDF
Abstract

The development of hyperphospholipidemia and hypercholesterolemia was studied in infants that required total parenteral nutrition and given a continuous infusion of Intralipid, (1-4 g/kg body wt per 24 h. Detailed studies were carried out on infusion periods lasting 1-10 d. After 24 h there was a marked increase in plasma free cholesterol (68%) and phospholipid (77%) concentrations. Based on the amount of cholesterol in Intralipid, and the rate of infusion, it was estimated that at least 50% of the plasma cholesterol increment during 64-h infusions was derived from endogenous sources. By contrast, the hyperphospholipidemia could be attributed to the Intralipid as the rise in plasma was calculated to be equivalent to only 16% of the exogenous phospholipid infused. Approximately 10% of the phospholipid in Intralipid was in a triglyceride-free mesophase form with a free cholesterol:phospholipid molar ratio of 0.063. There were no systematic changes in plasma concentrations of cholesterol ester or triglyceride during Intralipid infusions. The increase in free cholesterol and phospholipid was localized in the low density lipoproteins (d = 1.006-1.063 g/ml). The presence of lipoprotein X (Lp-X) in the low density lipoprotein fraction was demonstrated by electrophoresis in agar and by isolation and chemical characterization with hydroxylapatite chromatography. Isoelectric focusing of urea-soluble protein of Lp-X revealed that albumin and apolipoproteins CII and CIII were major components, whereas apolipoprotein E and AI were minor constituents. The abnormal lipoprotein was apparent by 16 h during 64 h of infusion. After 6 d of continuous infusions the free cholesterol in Lp-X was 30±10 mg/dl (mean±SD), which represents a total Lp-X mass of 90 mg/dl. After cessation of the infusion, Lp-X, as monitored by electrophoresis in agar, disappeared within 72-96 h. Thus, during infusion of Intralipid in infants at rates commonly employed, the capacity of the clearance mechanisms for phospholipid are exceeded, which causes the accumulation of phospholipid and free cholesterol in the form of Lp-X particles. It is suggested that mesophase phospholipids in Intralipid may play a significant role in this process.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1703
page 1703
icon of scanned page 1704
page 1704
icon of scanned page 1705
page 1705
icon of scanned page 1706
page 1706
icon of scanned page 1707
page 1707
icon of scanned page 1708
page 1708
icon of scanned page 1709
page 1709
icon of scanned page 1710
page 1710
icon of scanned page 1711
page 1711
icon of scanned page 1712
page 1712
Version history
  • Version 1 (December 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts